Insights

Innovative Technology Platform Nanobiosym's proprietary diagnostic technology offers rapid, accurate detection of genetic fingerprints, presenting opportunities to partner with healthcare providers, diagnostics companies, and global health organizations seeking innovative solutions for rapid and affordable testing.

Global Humanitarian Focus With a strong emphasis on addressing unmet needs in global health and environmental challenges, there are potential collaborations with NGOs, governments, and international agencies aiming to deploy life-saving technologies in developing regions.

Emerging Market Potential Despite a current revenue range of under one million dollars, the company’s focus on scalable nanotechnology solutions positions it well for growth as it expands into emerging markets requiring cost-effective diagnostic tools.

Strategic Public-Private Partnerships Nanobiosym’s initiative to forge partnerships with global thought leaders indicates opportunities for joint ventures, grants, and collaborative projects to accelerate deployment and commercialization efforts worldwide.

Technology Stack Compatibility Utilizing common tools like MySQL, Android, and Apache, Nanobiosym’s adaptable tech infrastructure suggests readiness for integration with existing digital health ecosystems, enabling easier adoption by healthcare and tech industries seeking seamless solutions.

Nanobiosym Tech Stack

Nanobiosym uses 8 technology products and services including Simulink, MySQL, ISO/IEC 27001, and more. Explore Nanobiosym's tech stack below.

  • Simulink
    Advanced Analytics And Data Science
  • MySQL
    Database
  • ISO/IEC 27001
    Governance, Risk And Compliance
  • National Instruments
    Miscellaneous
  • Microsoft Word
    Office Suites
  • Android
    Programming Languages
  • Google Analytics
    Web Analytics
  • Apache
    Web Servers

Media & News

Nanobiosym's Email Address Formats

Nanobiosym uses at least 1 format(s):
Nanobiosym Email FormatsExamplePercentage
FLast@nanobiosym.comJDoe@nanobiosym.com
47%
FirstL@nanobiosym.comJohnD@nanobiosym.com
3%
FLast@nanobiosym.comJDoe@nanobiosym.com
47%
FirstL@nanobiosym.comJohnD@nanobiosym.com
3%

Frequently Asked Questions

Where is Nanobiosym's headquarters located?

Minus sign iconPlus sign icon
Nanobiosym's main headquarters is located at 245 1st Street, Cambridge, MA 02142, US. The company has employees across 1 continents, including North America.

What is Nanobiosym's phone number?

Minus sign iconPlus sign icon
You can contact Nanobiosym's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nanobiosym's official website and social media links?

Minus sign iconPlus sign icon
Nanobiosym's official website is nanobiosym.com and has social profiles on LinkedIn.

How much revenue does Nanobiosym generate?

Minus sign iconPlus sign icon
As of October 2025, Nanobiosym's annual revenue is estimated to be $5.6M.

What is Nanobiosym's SIC code NAICS code?

Minus sign iconPlus sign icon
Nanobiosym's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541713 - Research and Development in Nanotechnology.

How many employees does Nanobiosym have currently?

Minus sign iconPlus sign icon
As of October 2025, Nanobiosym has approximately 11 employees across 1 continents, including North America. Key team members include Private Investor: P. V. N.Executive Assistant: J. W.Research Scientist: S. M.. Explore Nanobiosym's employee directory with LeadIQ.

What industry does Nanobiosym belong to?

Minus sign iconPlus sign icon
Nanobiosym operates in the Nanotechnology Research industry.

What technology does Nanobiosym use?

Minus sign iconPlus sign icon
Nanobiosym's tech stack includes SimulinkMySQLISO/IEC 27001National InstrumentsMicrosoft WordAndroidGoogle AnalyticsApache.

What is Nanobiosym's email format?

Minus sign iconPlus sign icon
Nanobiosym's email format typically follows the pattern of FLast@nanobiosym.com. Find more Nanobiosym email formats with LeadIQ.

When was Nanobiosym founded?

Minus sign iconPlus sign icon
Nanobiosym was founded in 2004.
Nanobiosym

Nanobiosym

Nanotechnology ResearchUnited States11-50 Employees

Nanobiosym® (NBS) is an innovation engine dedicated to creating a new science that emerges from the holistic integration of physics, biomedicine, and nanotechnology. NBS focuses on incubating transformational technologies that have the potential for game-changing impact and commercializing and scaling up these technologies for deployment in developed and developing world markets. NBS leverages science and technology to address our planet’s greatest unmet needs in global health, energy and the environment. Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of its proprietary technology platform, that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health. To maximize global humanitarian impact, we have spearheaded the Nanobiosym Global Initiative, which is building innovative public-private partnerships with governments, NGO’s, academic, industrial and global thought leaders to help bring emerging technologies to address some of the world’s most pressing challenges.

Section iconCompany Overview

Headquarters
245 1st Street, Cambridge, MA 02142, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541713 - Research and Development in Nanotechnology
Founded
2004
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    Nanobiosym's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Nanobiosym's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.